review authors must now disclose financial ties, but some want tougher rules
The editors of the
The paper on treatments for mood disorders, by Charles B. Nemeroff and Michael J. Owens of Emory University School of Medicine in Atlanta, included three products to which Nemeroff had significant financial ties.
In February of this year, Robert T. Rubin of the Center for Neurosciences Research, Allegheny General Hospital, and Bernard J. Carroll of the Pacific Behavioral Research Foundation, wrote ...
A citizen science game explores how social choices and networks can influence how an illness moves through a population.
View this Issue
Learn how a next-generation platform accelerates biological research by enabling high-throughput, spatially resolved multiomics profiling.
In this webinar, Imogen Binnian will share how AI and gene synthesis technology can accelerate the discovery and validation of novel disease traits.
Real-time imaging enhances fluorescence activated cell sorting (FACS) to help scientists overcome the cost and burden of validation.
New innovations provide scientists with easy access to robust and accurate control samples for quality control applications.
The Wellcome Sanger Institute, Helmholtz Munich, and Parse Biosciences have announced a landmark international collaboration to create a Cancer Plasticity Atlas.
Multi-center project will profile over 40,000 samples using ultra-sensitive NULISA™ technology.
Discover how Alderley Analytical meet regulatory demands and high-throughput challenges—processing 10,000+ dirty samples with consistent performance of the Xevo TQ Absolute XR Mass Spectrometer.
Collaboration combines Nuclera's eProtein Discovery System, which accelerates protein expression, purification and optimization, with Cytiva's Biacore SPR system, which characterizes molecular interactions
